Thrive Health Tirzepatide/Cyanocobalamin Injectable Recall

Why it was recalled

Lack of Assurance of Sterility

Product description

Tirzepatide/Cyanocobalamin Injectable, 30mg/1mg/mL (15mg/0.5mg/0.5mL), pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112

Lot numbers, UPCs & expiration codes

Lot: C03125A

Where it was sold

USA Nationwide

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0486-2025
Classification: Class II
Status: Ongoing
Recall initiated: May 21, 2025
FDA report date: Jul 2, 2025
Quantity: 242 syringes
Recall type: Voluntary: Firm initiated
Recalling firm: Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

Original FDA data

Every field from FDA enforcement report D-0486-2025, exactly as published.

Show all FDA fields

City: Englewood
State: CO
Status: Ongoing
Country: United States
Event ID: 96742
Address: 88 Inverness Cir E Unit A204
Code information: Lot: C03125A
Postal code: 80112-5521
Report date: Jul 2, 2025
Product type: Drugs
Recall number: D-0486-2025
Classification: Class II
Recalling firm: Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)
Product quantity: 242 syringes
Reason for recall: Lack of Assurance of Sterility
Voluntary / mandated: Voluntary: Firm initiated
Product description: Tirzepatide/Cyanocobalamin Injectable, 30mg/1mg/mL (15mg/0.5mg/0.5mL), pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112
Distribution pattern: USA Nationwide
Recall initiation date: May 21, 2025
Initial firm notification: E-Mail
Center classification date: Jun 20, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0486-2025, published Jul 2, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) Tirzepatide/Cyanocobalamin Injectable Recall

Summary